Pharmacy - Heart Screen UK

Home
Overview
Pharmacy
Workplace Health
Technology
Heart Health
News
FAQs
Results
Contact
About
T&Cs

Menu Close

Home
Overview
Pharmacy
Workplace Health
Technology
Heart Health
News
FAQs
Results
Contact
About
T&Cs

BECOME ONE OF THE FIRST TO OFFER THE CARDISIO HEART TEST TO YOUR COMMUNITY

Pharmacy Benefits

Pharmacy FAQs

Pharmacy - Patient Information Sheet

The NHS primary Care Study

Pharmacy Benefits

Why the Cardisio heart test is a perfect fit in Pharmacy?

The 2023 NHS Primary Care Study provided the proof that Cardisio is a perfect fit for Pharmacy, Please click here to download a copy of the Full Study Report

Trusted relationship with the local community

Deepen, strengthen relationships with your community

Relationship with GPs

Additional private, paid for service to offer to anyone over the age of 18

Additional revenue stream.

Increased footfall in Pharmacy

Pharmacy FAQs

Why is checking your heart health so important?

Heart disease is the leading cause of death in the UK, with conditions like coronary artery disease (CAD) often showing no symptoms until its too late. This risk isn’t limited to older adults; it can affect anyone, regardless of age or gender.

Statistics from the British Heart Foundation and NHS England states that that cardiovascular disease (CVD) remains one of the leading health challenges in the UK.

Why People choose the Cardisio heart test?

The Cardisio heart test is revolutionary in its ability to detect heart disease at its earliest stages, especially coronary artery disease (CAD), long before symptoms become evident. Traditional methods often identify heart conditions only once significant damage has already occurred. By utilising advanced vectorcardiography (VCG) and artificial intelligence technology, Cardisio offers you the chance to protect your heart health proactively.

Why is checking heart health important?
Currently, heart health testing is not routinely offered in the UK, and there is no national heart disease screening program in place. This makes the Cardisio test a unique and accessible option for anyone over the age of 18 who wants to assess their heart health and take preventive action.

Early detection of heart disease can dramatically reduce your risk of severe complications and improve your long-term health outcomes. The Cardisio test is non-invasive, fast and accurate, offering peace of mind without the need for hospital visits.

What are the benefits of having a Cardisio Heart Test?

Early identification of Cardiovascular disease can dramatically improve your chances of avoiding the progression of the disease. The Cardisio test report provides accurate measurements which help guide doctors to identify treatments or lifestyle changes, which will protect your heart.

Who should get tested?

Anyone who just wants to be certain their heart is in tip-top condition.
Anyone who is about to start exercising or join a gym or plan a 5K run or a marathon.
Those who have a family history of heart disease.
Those who smoke or are overweight.
Anyone with diabetes, high blood pressure or cholesterol issues.
If you experience symptoms such as shortness of breath, fatigue or chest discomfort.

What are the key benefits of the Cardisio Heart test in Pharmacy?

Non-invasive: Just five electrodes placed on your chest and back—no needles, no discomfort.
Fast & Efficient: The test takes just 4 minutes, with results available immediately.
Accurate & Reliable: Proven to have a sensitivity of 95.4% and specificity of 90% in detecting CAD.
Cost-effective
Convenient: Performed at Wansford Pharmacy, with no need for a hospital visit.

Pharmacy - Patient Information Sheet

The NHS primary Care Study

Please click here to download a copy of the Full Study Report

Here is a summary of the study report:

The SBRI Study (ref: SBRIH21P3013) was designed to collect real-world evidence on the effectiveness of the Cardisio Test as a tool for early detection of cardiovascular disease (CVD) in primary care settings within the UK’s National Health Service (NHS).

The study was funded by Nottingham University Hospitals NHS Trust and Cardisio UK, and oversight was provided by SBRI Healthcare Ltd.

Key objectives of the study included:

● Demonstrating the ease of integration of the Cardisio Test into existing NHS CVD prevention pathways.

● Evaluating the test’s performance in community settings, such as GP surgeries, pharmacies and community centres.

● Gathering feedback from healthcare professionals and patients on the user experience and benefits of the test.

Benefits of the Cardisio Test highlighted by the study:

● Accuracy and Early Detection: The Cardisio Test, using vectorcardiography and AI-based analysis, can accurately detect early signs of heart disease. This is crucial for early intervention and improved patient outcomes.

● Accessibility and Ease of Use: The test is designed to be administered by non-clinical staff in community settings, eliminating the need for specialized knowledge or extensive training. This increases accessibility to heart health screening for a wider population.

● Reduced Patient Journeys and Carbon Footprint: By enabling testing in primary care settings close to patients’ homes, the Cardisio Test significantly reduces the need for travel to hospitals. This translates to lower carbon emissions and aligns with the NHS’s sustainability goals.

● Improved Referral Efficiency: The test provides detailed reports that assist primary care clinicians in making more informed decisions about referrals to secondary care. This has the potential to reduce unnecessary referrals, freeing up resources and reducing waiting times.

● Cost-Effectiveness: By identifying potential CVD cases early and facilitating efficient referrals, the Cardisio Test could lead to significant cost savings for the NHS.

Overall, the SBRI study suggests that the Cardisio Test has the potential to improve the early detection and management of CVD in the UK. The study provides valuable insights for a wider rollout of the test within the NHS, highlighting its benefits for patients, healthcare providers and the overall healthcare system.

Site contains © copyright materials and ® Trademarks owned by Cardisio and Heart Screen UK Ltd. All content, products and services are subject to Heart Screen UK Ltd’s Terms and Conditions

Manage Cookie Consent

To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional Functional Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

View preferences

{title} {title} {title}